-
Je něco špatně v tomto záznamu ?
Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin
M. Raffaele, K. Kovacovicova, J. Frohlich, O. Lo Re, S. Giallongo, JA. Oben, M. Faldyna, L. Leva, AG. Giannone, D. Cabibi, M. Vinciguerra
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
CZ.02.1.01/0.0/0.0/15_003/0000492
European Social Fund
NV18-03-00058
Ministerstvo Zdravotnictví Ceské Republiky (CZ)
RO0518
Ministerstvo Zemědělství
856871
Horizon 2020 Framework Programme
NLK
BioMedCentral
od 2003-12-01
BioMedCentral Open Access
od 2003
Directory of Open Access Journals
od 2003
Free Medical Journals
od 2003
PubMed Central
od 2003
Europe PubMed Central
od 2003
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2003-08-01
Open Access Digital Library
od 2003-01-01
Open Access Digital Library
od 2003-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2003
Springer Nature OA/Free Journals
od 2003-12-01
- MeSH
- dasatinib škodlivé účinky MeSH
- dieta s vysokým obsahem tuků MeSH
- diethylnitrosamin MeSH
- léky proti stárnutí škodlivé účinky MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední C57BL MeSH
- nealkoholová steatóza jater krev genetika patologie MeSH
- nemoci jater krev genetika patologie MeSH
- obezita krev genetika patologie MeSH
- progrese nemoci * MeSH
- quercetin škodlivé účinky MeSH
- regulace genové exprese MeSH
- stárnutí genetika patologie MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. A minority of affected patients develops inflammation, subsequently fibrosis, cirrhosis and hepatocellular carcinoma (HCC). HCC is a leading cause of cancer-related death. An increased number of senescent cells correlate with age-related tissue degeneration during NAFLD-induced HCC. Senolytics are promising agents that target selectively senescent cells. Previous studies showed that whereas a combination of the senolytic drugs dasatinib and quercetin (D + Q) reduced NAFLD in mice, D + Q lacked efficacy in removing doxorubicin-induced β-gal-positive senescent cells in human HCC xenografted mice. Whether D + Q has an effect on the age-associated spectrum of NAFLD-inflammation-HCC remains unknown. METHODS: Here, we utilized an established model of age- and obesity-associated HCC, the low dose diethylnitrosamine (DEN)/high fat diet (HFD), a regimen promoting liver inflammation and tumorigenesis over a long period of 9 months. Four groups of mice each were created: group 1 included control untreated mice; group 2 included mice treated with D + Q; group 3 included mice undergoing the DEN/HFD protocol; group 4 included mice undergoing the DEN/HFD protocol with the administration of D + Q. At the end of the chemical/dietary regimen, we analyzed liver damage and cell senescence by histopathology, qPCR and immunoblotting approaches. RESULTS: Unexpectedly, D + Q worsened liver disease progression in the DEN/HFD mouse model, slightly increasing histological damage and tumorigenesis, while having no effect on senescent cells removal. CONCLUSIONS: In summary, using an animal model that fully recapitulates NAFLD, we demonstrate that these compounds are ineffective against age-associated NAFLD-induced HCC. Video Abstract.
Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic
ERA Chair in Translational Stem Cell Biology Medical University of Varna Varna Bulgaria
Institute for Liver and Digestive Health London UK
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012477
- 003
- CZ-PrNML
- 005
- 20220506130422.0
- 007
- ta
- 008
- 220425s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12964-021-00731-0 $2 doi
- 035 __
- $a (PubMed)33832488
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Raffaele, Marco $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. marco.raffaele@fnusa.cz $1 https://orcid.org/0000000192324587
- 245 10
- $a Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin / $c M. Raffaele, K. Kovacovicova, J. Frohlich, O. Lo Re, S. Giallongo, JA. Oben, M. Faldyna, L. Leva, AG. Giannone, D. Cabibi, M. Vinciguerra
- 520 9_
- $a BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. A minority of affected patients develops inflammation, subsequently fibrosis, cirrhosis and hepatocellular carcinoma (HCC). HCC is a leading cause of cancer-related death. An increased number of senescent cells correlate with age-related tissue degeneration during NAFLD-induced HCC. Senolytics are promising agents that target selectively senescent cells. Previous studies showed that whereas a combination of the senolytic drugs dasatinib and quercetin (D + Q) reduced NAFLD in mice, D + Q lacked efficacy in removing doxorubicin-induced β-gal-positive senescent cells in human HCC xenografted mice. Whether D + Q has an effect on the age-associated spectrum of NAFLD-inflammation-HCC remains unknown. METHODS: Here, we utilized an established model of age- and obesity-associated HCC, the low dose diethylnitrosamine (DEN)/high fat diet (HFD), a regimen promoting liver inflammation and tumorigenesis over a long period of 9 months. Four groups of mice each were created: group 1 included control untreated mice; group 2 included mice treated with D + Q; group 3 included mice undergoing the DEN/HFD protocol; group 4 included mice undergoing the DEN/HFD protocol with the administration of D + Q. At the end of the chemical/dietary regimen, we analyzed liver damage and cell senescence by histopathology, qPCR and immunoblotting approaches. RESULTS: Unexpectedly, D + Q worsened liver disease progression in the DEN/HFD mouse model, slightly increasing histological damage and tumorigenesis, while having no effect on senescent cells removal. CONCLUSIONS: In summary, using an animal model that fully recapitulates NAFLD, we demonstrate that these compounds are ineffective against age-associated NAFLD-induced HCC. Video Abstract.
- 650 _2
- $a stárnutí $x genetika $x patologie $7 D000375
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a dasatinib $x škodlivé účinky $7 D000069439
- 650 _2
- $a dieta s vysokým obsahem tuků $7 D059305
- 650 _2
- $a diethylnitrosamin $7 D004052
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 12
- $a progrese nemoci $7 D018450
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a nemoci jater $x krev $x genetika $x patologie $7 D008107
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a nealkoholová steatóza jater $x krev $x genetika $x patologie $7 D065626
- 650 _2
- $a obezita $x krev $x genetika $x patologie $7 D009765
- 650 _2
- $a quercetin $x škodlivé účinky $7 D011794
- 650 _2
- $a léky proti stárnutí $x škodlivé účinky $7 D000089322
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kovacovicova, Kristina $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Frohlich, Jan $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Lo Re, Oriana $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Giallongo, Sebastiano $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Oben, Jude A $u Institute for Liver and Digestive Health (ILDH), Division of Medicine, University College London (UCL), London, UK
- 700 1_
- $a Faldyna, Martin $u Veterinary Research Institute, Brno, Czech Republic
- 700 1_
- $a Leva, Lenka $u Veterinary Research Institute, Brno, Czech Republic
- 700 1_
- $a Giannone, Antonino Giulio $u Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Pathologic Anatomy Unit-University of Palermo, Palermo, Italy
- 700 1_
- $a Cabibi, Daniela $u Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Pathologic Anatomy Unit-University of Palermo, Palermo, Italy
- 700 1_
- $a Vinciguerra, Manlio $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. manlio.vinciguerra@fnusa.cz $u Institute for Liver and Digestive Health (ILDH), Division of Medicine, University College London (UCL), London, UK. manlio.vinciguerra@fnusa.cz $u ERA Chair in Translational Stem Cell Biology, Medical University of Varna, Varna, Bulgaria. manlio.vinciguerra@fnusa.cz
- 773 0_
- $w MED00008216 $t Cell communication and signaling : CCS $x 1478-811X $g Roč. 19, č. 1 (2021), s. 44
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33832488 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130414 $b ABA008
- 999 __
- $a ok $b bmc $g 1789892 $s 1163678
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 19 $c 1 $d 44 $e 20210408 $i 1478-811X $m Cell communication and signaling $n Cell Commun Signal $x MED00008216
- GRA __
- $a CZ.02.1.01/0.0/0.0/15_003/0000492 $p European Social Fund
- GRA __
- $a NV18-03-00058 $p Ministerstvo Zdravotnictví Ceské Republiky (CZ)
- GRA __
- $a RO0518 $p Ministerstvo Zemědělství
- GRA __
- $a 856871 $p Horizon 2020 Framework Programme
- LZP __
- $a Pubmed-20220425